I attended, and led a seminar at, the third annual Preventing Overdiagnosis conference in Washington, DC this week. My talk was on “The role of the media in preventing or promoting overdiagnosis.” My slides are now posted on SlideShare.
Role of the media in preventing or promoting overdiagnosis from Gary Schwitzer
HealthNewsReview.org contributors Alan Cassels, Dr. Susan Molchan and Dr. James Rickert were speakers or participants in the conference.
In coming weeks, we will publish audio podcast interviews with interesting people with different perspectives from the conference:
The conference website will soon provide videos of keynote presentations and other video interviews with speakers and attendees. Check back to that website if you’re interested in learning more.
Meantime, see Bernadette Keefe’s Storify account of the conference.
Addendum on September 8: Allen Frances, MD, wrote on a Huffington Post blog, “My Summary of a Great Conference: ‘Preventing Overdiagnosis’ 2015.”
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments (5)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Al Lewis
September 4, 2015 at 7:13 pmI’m totally supportive of your efforts but you are giving workplace wellness programs a free ride. My website http://www.theysaidwhat.net has example after example of wellness vendors screening the stuffing out of employees, who face fines if they don’t capitulate. Then the vendors brag about all the sick people they find. We even have a term for that: Hyperdiagnosis
Gary Schwitzer
September 4, 2015 at 8:56 pmAl,
My talk was – as labeled – about “The role of the media in preventing or promoting over diagnosis.”
So I’m not giving anyone in workplace wellness “a free ride.” That’s just not what my talk was about.
Gary Schwitzer
Imran Ali MD
September 7, 2015 at 1:24 amAmazing, So proud that you are bringing this to light. I am trying my very best to take all of this into account as I begin my journey to becoming a medical journalist
Imran Ali MD
September 7, 2015 at 1:26 amI look forward to seeing you at the ACC conference this December and will encourage my friends at ABC News and CNN to come
James Rickert, MD
September 7, 2015 at 10:59 amThis presentation was among the most engaging at the Preventing Overdiagnosis Conference. Without understanding the role that the media plays in driving inappropriate medical care, we won’t be able to solve the problem.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like